What does Remopharma do?
Remopharma is a pharmaceutical company that specializes in the development and manufacturing of high-quality generic drugs. It focuses on providing affordable healthcare solutions while ensuring compliance with stringent regulatory standards. The company aims to enhance patient access to essential medications through innovation and efficiency in its production processes.
- Sectors
- Pharmacies
- Signals
-
ProfitableProfitable € 241K
The company reported a positive net result in the latest financial year.
Strong equityStrong equity € 2.21MStrong equity provides a buffer against setbacks.
Low riskLow risk 60.2%Good solvency (> 30%) points to long-term financial stability.
Good liquidityGood liquidity 1.83A healthy current ratio (≥ 1.5): enough current assets to cover short-term debt.
Positive cashflowPositive cashflow € 447KPositive operating cash flow in the latest financial year.
Positive EBITDAPositive EBITDA € 622KPositive EBITDA: operating activities are profitable.
Healthy social debtHealthy social debt 12.2%Social debts stay manageable relative to personnel costs.
Financial ratios
|
|
2025
|
2024
|
2023
|
2009
|
|---|---|---|---|---|
|
€
1.10M
|
€
965K
|
€
932K
|
€
162K
|
|
|
€
622K
|
€
621K
|
€
617K
|
€
132K
|
|
|
€
241K
|
€
296K
|
€
304K
|
€
22K
|
|
|
€
2.21M
|
€
1.96M
|
€
1.67M
|
€
138K
|
|
|
60.19%
|
59.31%
|
51.32%
|
17.99%
|
|
|
€
1.46M
|
€
1.35M
|
€
1.58M
|
€
629K
|
|
|
€
659K
|
€
695K
|
€
629K
|
€
153K
|
|
|
6.90
|
6.70
|
4.80
|
|
Publications 5
All publications- Statuten (Vertaling, Cordinatie, Overige Wijzigingen, ) - Wijziging Rechtsvorm - Ontslagen - Benoemingen 19/12/2023
- Kapitaal - Aandelen - Statuten (Vertaling, Cordinatie, Overige Wijzigingen, ) 04/01/2018
- Ontslagen - Benoemingen 18/07/2012
- Me. - Jaarrekening 31.12.2009, Ggk 30.06.2010, Ngl 07.07.2010 10292-0530-009 16/07/2010
- Rubriek Oprichting (Nieuwe Rechtspersoon, Opening Bijkantoor, Enz...) 02/10/2008
Frequently asked questions
Answers to the most common questions about Remopharma, based on official government data and the filed annual accounts.
What is the VAT number of Remopharma?
The VAT number of Remopharma is BE0806.560.542.
How many employees work at Remopharma?
In 2025, Remopharma employed 6.90 full-time equivalents (FTE).
When was Remopharma established?
Remopharma was founded in 24-09-2008.
What is the official address of Remopharma?
The official address of Remopharma is Meerdonkdorp(Md) 24 Sint-Gillis-Waas 9170.
What is the legal form of Remopharma?
The juridical form of Remopharma is Private limited company (BV/SRL).
What is the annual revenue of Remopharma?
The 2025 accounts of Remopharma do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.
What does Remopharma do?
Remopharma is a pharmaceutical company that specializes in the development and manufacturing of high-quality generic drugs. It focuses on providing affordable healthcare solutions while ensuring compliance with stringent regulatory standards. The company aims to enhance patient access to essential medications through innovation and efficiency in its production processes.
Is Remopharma a reliable company?
Remopharma is a registered Rechtspersoon with company number 0806.560.542 and can be verified through the official CBE database.
What is the credit limit of Remopharma?
The estimated credit limit of Remopharma is €714,310.
Is Remopharma still active?
Remopharma currently has the status "Normal situation" and is active.